| 000 | 01623 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514001228.0 | ||
| 264 | 0 | _c20011011 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a1058-2916 | ||
| 024 | 7 |
_a10.1097/00002480-200105000-00025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKing, B O | |
| 245 | 0 | 0 |
_aTirofiban administration attenuates platelet and platelet-neutrophil conjugation but not neutrophil degranulation during in vitro VAD circulation. _h[electronic resource] |
| 260 |
_bASAIO journal (American Society for Artificial Internal Organs : 1992) _c |
||
| 300 |
_a282-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 |
_aCell Degranulation _xdrug effects |
| 650 | 0 | 4 | _aComplement Activation |
| 650 | 0 | 4 | _aHeart-Assist Devices |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLeukocyte Elastase _xmetabolism |
| 650 | 0 | 4 |
_aLeukotriene C4 _xmetabolism |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Factor 4 _xmetabolism |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xmetabolism |
| 650 | 0 | 4 | _aTirofiban |
| 650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
| 700 | 1 | _aWhittow, E S | |
| 700 | 1 | _aSerna, D L | |
| 700 | 1 | _aJones, B U | |
| 700 | 1 | _aEng, J S | |
| 700 | 1 | _aChen, J C | |
| 773 | 0 |
_tASAIO journal (American Society for Artificial Internal Organs : 1992) _gvol. 47 _gno. 3 _gp. 282-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002480-200105000-00025 _zAvailable from publisher's website |
| 999 |
_c11306546 _d11306546 |
||